Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Gowell Pharmaceutical Co., Ltd., a key subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd., is a prominent pharmaceutical company based in Chengdu, China. Established in 2003, the company specializes in the research, development, and large-scale manufacturing of chemical drugs, including active pharmaceutical ingredients (APIs) and finished dosage forms. Its extensive product portfolio primarily addresses therapeutic areas such as anti-infectives, cardiovascular diseases, parenteral nutrition, and diagnostic imaging. Gowell operates state-of-the-art manufacturing facilities that adhere to stringent GMP standards, ensuring the production of safe and effective medicines for both domestic and international markets. As a vital component of the Kelun Group, the company plays a significant role in providing affordable healthcare solutions through manufacturing excellence and high-end formulation technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Gowell Pharmaceutical.